(1)
de Bruin-Weller, M.; Thaci, D.; Smith, C.; Radin, A.; Zhang, R.; Akinlade, B.; Gadkari, A.; Eckert, L.; Hultsch, T.; Pirozzi, G.; Graham, N. M.; Shumel, B. Dupilumab With Concomitant Topical Corticosteroids in Atopic Dermatitis Patients Who Are Inadequately Controlled With or Medically Inadvisable for Cyclosporine A: A Phase 3 Clinical Trial (LIBERTY AD CAFE). J of Skin 2017, 1, s37.